SUIT-001 O2 ce-pce D003: Difference between revisions
No edit summary |
No edit summary |
||
Line 6: | Line 6: | ||
|SUIT number=D003_ce1;1Dig;1PM;2D;2c;3U;4G;5S;6Oct;7Rot;8Gp;9Ama;10AsTm;11Azd | |SUIT number=D003_ce1;1Dig;1PM;2D;2c;3U;4G;5S;6Oct;7Rot;8Gp;9Ama;10AsTm;11Azd | ||
}} | }} | ||
::: [[MitoPedia: SUIT]] - '''[[SUIT reference protocol]] RP1 for permeabilized cells''' | ::: '''[[MitoPedia: SUIT]]''' - '''[[SUIT reference protocol]] RP1 for permeabilized cells''' | ||
::: '''[[Categories of SUIT protocols |SUIT-category]]:''' FNSGp(Oct,PGM) | ::: '''[[Categories of SUIT protocols |SUIT-category]]:''' FNSGp(Oct,PGM) | ||
::: '''[[SUIT protocol pattern]]:''' orthogonal 1PM;2D;2c;3U;4G;5S;6Oct;7Rot;8Gp- | ::: '''[[SUIT protocol pattern]]:''' orthogonal 1PM;2D;2c;3U;4G;5S;6Oct;7Rot;8Gp- | ||
The SUIT-001 O2 pce D003 protocol in combination with [[SUIT-002 O2 pce D007]] is specially designed to provide a common reference for comparison of respiratory control of permeabilized cells in a wide variety of | The SUIT-001 O2 pce D003 protocol in combination with [[SUIT-002 O2 pce D007]] is specially designed to provide a common reference for comparison of respiratory control of permeabilized cells in a wide variety of cell types. SUIT-001 O2 pc D003 gives information of the linear coupling control ([[LEAK-respiration|''L'']]-[[Oxidative phosphorylation| ''P'']]-[[ET-capacity| ''E'']]) with NADH linked-substrates ([[PM pathway control state|PM]]). Moreover, the pathway control in ET state ([[NADH_Electron_transfer-pathway_state|N]], [[NS-pathway control state| NS]], [[FNS]], [[Succinate pathway control state| S]] and [[SGp-pathway control state| SGp]] pathways) can be evaluated by using this SUIT protocol. SUIT-001 O2 pce D003 can be extended with the CIV assay module. | ||
__TOC__ | __TOC__ | ||
Communicated by [[Doerrier C]] and [[Gnaiger E]] (last update 2019-03-06) | |||
{{Template:SUIT-001 pce}} | {{Template:SUIT-001 pce}} | ||
Line 48: | Line 49: | ||
== References == | == References == | ||
{{#ask:[[Category:Publications]] [[Additional label::SUIT-001 O2 pce D003]] | {{#ask:[[Category:Publications]] [[Additional label::SUIT-001 O2 pce D003]] [[Additional label::SUIT-001]] | ||
| ?Was published in year=Year | | ?Was published in year=Year | ||
| ?Has title=Reference | | ?Has title=Reference | ||
Line 66: | Line 67: | ||
|mitopedia method=Respirometry | |mitopedia method=Respirometry | ||
}} | }} | ||
Revision as of 13:24, 6 March 2019
Description
Abbreviation: FNSGp(Oct,PGM)
Reference: A Reference protocol RP1; pce: permeabilized cells - SUIT-001
SUIT number: D003_ce1;1Dig;1PM;2D;2c;3U;4G;5S;6Oct;7Rot;8Gp;9Ama;10AsTm;11Azd
O2k-Application: O2
- MitoPedia: SUIT - SUIT reference protocol RP1 for permeabilized cells
- SUIT-category: FNSGp(Oct,PGM)
- SUIT protocol pattern: orthogonal 1PM;2D;2c;3U;4G;5S;6Oct;7Rot;8Gp-
The SUIT-001 O2 pce D003 protocol in combination with SUIT-002 O2 pce D007 is specially designed to provide a common reference for comparison of respiratory control of permeabilized cells in a wide variety of cell types. SUIT-001 O2 pc D003 gives information of the linear coupling control (L- P- E) with NADH linked-substrates (PM). Moreover, the pathway control in ET state (N, NS, FNS, S and SGp pathways) can be evaluated by using this SUIT protocol. SUIT-001 O2 pce D003 can be extended with the CIV assay module.
Communicated by Doerrier C and Gnaiger E (last update 2019-03-06)
Steps and respiratory states
Step | State | Pathway | Q-junction | Comment - Events (E) and Marks (M) |
---|---|---|---|---|
ce1 | ROUTINE | ce1
| ||
1Dig | REN | ce1;1Dig
|
Step | State | Pathway | Q-junction | Comment - Events (E) and Marks (M) |
---|---|---|---|---|
1PM | PML(n) | N | CI | 1PM
|
2D | PMP | N | CI | 1PM;2D
|
2c | PMcP | N | CI | 1PM;2D;2c
|
3U | PME | N | CI | 1PM;2D;3U
|
4G | PGME | N | CI | 1PM;2D;3U;4G
|
5S | PGMSE | NS | CI&II | 1PM;2D;3U;4G;5S
|
6Oct | OctPGMSE | FNS | FAO&CI&II | 1PM;2D;3U;4G;5S;6Oct
|
7Rot | SE | S | CII | 1PM;2D;3U;4G;5S;6Oct;7Rot
|
8Gp | SGpE | SGp | CII&GpDH | 1PM;2D;3U;4G;5S;6Oct;7Rot;8Gp
|
9Ama | ROX |
|
Step | Respiratory state | Pathway control | ET-Complex | Comment |
---|---|---|---|---|
## AsTm | AsTmE | CIV | CIV | |
## Azd | CHB |
- Bioblast links: SUIT protocols - >>>>>>> - Click on [Expand] or [Collapse] - >>>>>>>
- Coupling control
- Pathway control
- ยป Electron transfer pathway
- ยป Fatty acid oxidation pathway control state, F
- ยป NADH electron transfer-pathway state, N
- ยป Succinate pathway control state, S
- ยป NS-pathway control state, NS
- ยป Glycerophosphate pathway control state, Gp
- ยป Complex IV single step, CIV
- ยป Anaplerotic pathway control state
- Pathway control
- Main fuel substrates
- ยป Glutamate, G
- ยป Glycerophosphate, Gp
- ยป Malate, M
- ยป Octanoylcarnitine, Oct
- ยป Pyruvate, P
- ยป Succinate, S
- Main fuel substrates
- Glossary
Strengths and limitations
- SUIT-001 in combination with SUIT-002 provides a common reference for comparison of respiratory control in a large variety of species, tissues and cell types. Both SUIT protocols provide a mitochondrial mapping which allows:
- 1. to obtain reference values.
- 2. to evaluate mitochondrial physiological diversity, generating a mt-database on comparative mitochondrial physiology.
- 3. to screen specific defects.
- SUIT-001 and SUIT-002 are used in the MitoFit Proficiency test for inter-individual and inter-laboratory reproducibility quality control.
- A succinate concentration of >10 mM may be required for saturating SE capacity.
- + Linear coupling control (L-P-E) with N substrates (PM).
- + Pathway control in ET state (N, NS, FNS, S and SGp pathways).
- + Harmonization with SUIT-002 allows to perform both SUIT protocols in parallel. The cross-linked respiratory states can be statistically used as repeated measurements.
- + In cells, SUIT-001 and SUIT-002 harmonize in: ROUTINE (ce1), SGpE (8Gp in SUIT-001 and 10Rot in SUIT-002) and Complex IV.
- + Harmonization with many SUIT protocols (up to step 5S).
- + Oct is added in ET state to avoid uncoupler effect with fatty acids.
- + If NS- and FNS-pathways are similar (NSE ~ FNSE), the additivity index of N- and S-pathways in ET state can be evaluated.
- + This protocol can be extended with the Complex IV module.
- - The substrate combination for maximum ET capacity (FNSGP) is not obtained in SUIT-001 in favour of measuring SE.
- - Lengthy duration of the experiment.
Compare SUIT protocols
- SUIT-001 O2 pce D003 (general SUIT-001 for permeabilized cells) differs from SUIT-001 O2 pce D004 (SUIT-001 for permeabilized PBMCs and PLTs) in the presence and absence of octanoylcarnitine, respectively.
- SUIT-002 O2 pce D007 (RP2): Harmonized SUIT protocol for permeabilized cells.
References
MitoPedia concepts: SUIT protocol, SUIT A, Find
MitoPedia methods:
Respirometry